Hassard James 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Mar 10, 2022
Insider Transaction Report
Form 4
Hassard James
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-10+160,000→ 160,000 totalExercise: $19.73Exp: 2032-03-09→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The option is exercisable as follows: 25% of the shares subject to the option vest on February 28, 2023, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.